ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ACRX AcelRX Pharmaceuticals Inc

0.86
0.00 (0.00%)
Pre Market
Last Updated: 20:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.861
Ask Price 0.89
News -
Day High

Low
0.425

52 Week Range

High
1.42

Day Low
Company Name Stock Ticker Symbol Market Type
AcelRX Pharmaceuticals Inc ACRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.86 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.86
Trades Volume Avg Volume 52 Week Range
0 0 - 0.425 - 1.42
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.86 USD

AcelRX Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
14.58M 16.95M - 651k -18.4M -1.09 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

AcelRX Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ACRX Message Board. Create One! See More Posts on ACRX Message Board See More Message Board Posts

Historical ACRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.76980.87750.74430.8185808132,7740.090211.72%
6 Months0.56070.87750.4250.6530098135,1060.299353.38%
1 Year0.82261.420.4250.8141242191,4740.03744.55%
3 Years33.0034.400.42512.811,005,720-32.14-97.39%
5 Years65.0081.000.42528.481,349,547-64.14-98.68%

AcelRX Pharmaceuticals Description

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States.

Your Recent History

Delayed Upgrade Clock